The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals
Background: While there have been some studies looking at the impact on quality of life of
patients with idiopathic pulmonary fibrosis, to date no qualitative research looking at the …
patients with idiopathic pulmonary fibrosis, to date no qualitative research looking at the …
Genetic Variation in the Catechol-O-Methyltransferase (COMT) Gene and Morphine Requirements in Cancer Patients with Pain
TT Rakvåg, JR Ross, H Sato, F Skorpen… - Molecular …, 2008 - journals.sagepub.com
Background: Genetic variation contributes to differences in pain sensitivity and response to
different analgesics. Catecholamines are involved in the modulation of pain and are partly …
different analgesics. Catecholamines are involved in the modulation of pain and are partly …
No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients
J Riley, JR Ross, D Rutter, AU Wells, K Goller… - Supportive care in …, 2006 - Springer
Goals of work The aims of this study were (1) to prospectively evaluate the clinical benefits
of switching from morphine to an alternative opioid, using oxycodone as first-line alternative …
of switching from morphine to an alternative opioid, using oxycodone as first-line alternative …
Genetic variation and response to morphine in cancer patients: catechol‐O‐methyltransferase and multidrug resistance‐1 gene polymorphisms are associated with …
JR Ross, J Riley, AB Taegetmeyer… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND Pain is a common symptom for patients with cancer, and opioids are the
treatment of choice for moderate or severe cancer‐related pain. Central side effects, such as …
treatment of choice for moderate or severe cancer‐related pain. Central side effects, such as …
Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention
Background Those affected by advanced fibrotic interstitial lung diseases (ILDs) have
considerable unmet symptom and psychological needs. Case conferencing has been proposed to …
considerable unmet symptom and psychological needs. Case conferencing has been proposed to …
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature
Background Patients with fibrotic interstitial lung disease have symptom control and quality
of life (QoL) needs. This review aims to evaluate the evidence for the use of interventions in …
of life (QoL) needs. This review aims to evaluate the evidence for the use of interventions in …
Specialist palliative care is more than drugs: a retrospective study of ILD patients
Background This study aimed to assess the palliative care needs of progressive idiopathic
fibrotic interstitial lung disease (PIF-ILD) populations in two London ILD centres. Methods …
fibrotic interstitial lung disease (PIF-ILD) populations in two London ILD centres. Methods …
'I wish I knew more...'the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals
…, J Koffman, IJ Higginson, JR Ross… - BMJ supportive & …, 2013 - spcare.bmj.com
The importance at the end of life of developing effective communication and meeting information
needs is recognised as being central to enhance patient and family centred experience. …
needs is recognised as being central to enhance patient and family centred experience. …
Palliative care for people with non-malignant lung disease: summary of current evidence and future direction
Background: The physical and psychosocial needs of patients with chronic non-malignant
lung disease are comparable to those with lung cancer. This article will focus on chronic …
lung disease are comparable to those with lung cancer. This article will focus on chronic …
[HTML][HTML] Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial
…, M Thick, A Wells, J Williams, K Welsh, J Ross - Journal of Pain and …, 2015 - Elsevier
Context There is wide interindividual variation in response to morphine for cancer-related
pain; 30% of patients do not have a good therapeutic outcome. Alternative opioids such as …
pain; 30% of patients do not have a good therapeutic outcome. Alternative opioids such as …